Literature DB >> 7356473

Inhibition of tubulin polymerization by mebendazole.

J P Laclette, G Guerra, C Zetina.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7356473     DOI： 10.1016/0006-291x(80)90349-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN： 0006-291X            Impact factor:   3.575


× No keyword cloud information.
  22 in total

1.  Targeting acute myeloid leukemia by drug-induced c-MYB degradation.

Authors:  V Walf-Vorderwülbecke; K Pearce; T Brooks; M Hubank; M M van den Heuvel-Eibrink; C M Zwaan; S Adams; D Edwards; J Bartram; S Samarasinghe; P Ancliff; A Khwaja; N Goulden; G Williams; J de Boer; O Williams
Journal:  Leukemia       Date:  2017-11-01       Impact factor: 11.528

2.  Mebendazole Potentiates Radiation Therapy in Triple-Negative Breast Cancer.

Authors:  Le Zhang; Milana Bochkur Dratver; Taha Yazal; Kevin Dong; Andrea Nguyen; Garrett Yu; Amy Dao; Michael Bochkur Dratver; Sara Duhachek-Muggy; Kruttika Bhat; Claudia Alli; Frank Pajonk; Erina Vlashi
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-09-07       Impact factor: 7.038

3.  Genetic effects of methyl benzimidazole-2-yl-carbamate on Saccharomyces cerevisiae.

Authors:  J S Wood
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

4.  Influence of the antimicrotubule agent, mebendazole, on the secretory activity of intestinal cells of Ascaridia galli.

Authors:  C Atkinson; R J Newsam; K Gull
Journal:  Protoplasma       Date:  1980       Impact factor: 3.356

5.  Biological Evaluation of a Potential Anticancer Agent Methyl N-[5-(3'-Iodobenzoyl)-1H-Benzimidazol-2-yl]Carbamate.

Authors:  Zbigniew P Kortylewicz; Don W Coulter; Janina Baranowska-Kortylewicz
Journal:  Cancer Biother Radiopharm       Date:  2019-11-05       Impact factor: 3.099

6.  Predictions of genotoxic potential, mode of action, molecular targets, and potency via a tiered multiflow® assay data analysis strategy.

Authors:  Stephen D Dertinger; Andrew R Kraynak; Ryan P Wheeldon; Derek T Bernacki; Steven M Bryce; Nikki Hall; Jeffrey C Bemis; Sheila M Galloway; Patricia A Escobar; George E Johnson
Journal:  Environ Mol Mutagen       Date:  2019-02-27       Impact factor: 3.216

7.  Fasciola hepatica: tegumental surface changes in adult and juvenile flukes following treatment in vitro with the sulphoxide metabolite of triclabendazole (Fasinex).

Authors:  A W Stitt; I Fairweather
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

8.  Impairment of the ubiquitin-proteasome pathway by methyl N-(6-phenylsulfanyl-1H-benzimidazol-2-yl)carbamate leads to a potent cytotoxic effect in tumor cells: a novel antiproliferative agent with a potential therapeutic implication.

Authors:  Nilambra Dogra; Tapas Mukhopadhyay
Journal:  J Biol Chem       Date:  2012-06-28       Impact factor: 5.157

9.  Combination of albendazole and 2-methoxyestradiol significantly improves the survival of HCT-116 tumor-bearing nude mice.

Authors:  Anahid Ehteda; Peter Galettis; Krishna Pillai; David L Morris
Journal:  BMC Cancer       Date:  2013-02-23       Impact factor: 4.430

10.  The Saccharomyces cerevisiae NPS1 gene, a novel CDC gene which encodes a 160 kDa nuclear protein involved in G2 phase control.

Authors:  E Tsuchiya; M Uno; A Kiguchi; K Masuoka; Y Kanemori; S Okabe; T Mikayawa
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.